I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Once daily administration of the SGLT2 inhibitor, empaglifl..:
Gallo, Linda A
;
Ward, Micheal S
;
Fotheringham, Amelia K
...
qt7kx3t3xc. , 2016
Link:
https://escholarship.org/uc/item/7kx3t3xc
RT Journal T1
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt7kx3t3xc&Exemplar=1&LAN=DE A1 Gallo, Linda A A1 Ward, Micheal S A1 Fotheringham, Amelia K A1 Zhuang, Aowen A1 Borg, Danielle J A1 Flemming, Nicole B A1 Harvie, Ben M A1 Kinneally, Toni L A1 Yeh, Shang-Ming A1 McCarthy, Domenica A A1 Koepsell, Hermann A1 Vallon, Volker A1 Pollock, Carol A1 Panchapakesan, Usha A1 Forbes, Josephine M PB eScholarship, University of California YR 2016 K1 Diabetes K1 Kidney Disease K1 Biotechnology K1 Development of treatments and therapeutic interventions K1 5.1 Pharmaceuticals K1 Renal and urogenital K1 Metabolic and endocrine K1 Good Health and Well Being K1 Albuminuria K1 Animals K1 Benzhydryl Compounds K1 Biomarkers K1 Diabetes Mellitus K1 Experimental K1 Diabetic Nephropathies K1 Disease Models K1 Animal K1 Drug Administration Schedule K1 Glucosides K1 Hepatitis A Virus Cellular Receptor 1 K1 Hypoglycemic Agents K1 Lipocalin-2 K1 Male K1 Mice K1 Treatment Outcome JF qt7kx3t3xc LK http://dx.doi.org/https://escholarship.org/uc/item/7kx3t3xc DO https://escholarship.org/uc/item/7kx3t3xc SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)